ÂÜÀòÂÒÂ×

Alexander Podvysotsky serves as Chief Corporate Development Officer and Board Member at Neauvia / Matex Lab Group since August 2020, contributing to the company's status as a leading provider in the global aesthetic medicine sector, with products available in over 75 markets. Additionally, Alexander is a member of the Supervisory Board for ITP SA Biomedical Company and PATENT CO., which specializes in animal nutrition solutions. Prior experience includes an investment professional role at Abris Capital Partners from 2011 to 2020, and a member of the Supervisory Board for Kopernikus Technology. Early career highlights feature positions at Vega Telecom, BNP Paribas, and Deloitte, focusing on operational efficiency and strategy. Alexander holds advanced degrees in Finance and Economics from Nacional'nij Universitet 'Kievo-Mogiljans'ka Akademija', along with executive education from IESE and Harvard Business School, emphasizing board effectiveness and digital innovation.